ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer

Overview of attention for article published in Clinical Cancer Research, March 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 127,731 followers.

ERRα is a marker of tamoxifen response and survival in triple-negative breast cancer. https://t.co/S4ToZr8k6N

ERRα is a marker of tamoxifen response and survival in triple-negative breast cancer. https://t.co/5LLnSaI3uO

ERRα is a marker of tamoxifen response and survival in triple-negative breast cancer. https://t.co/SAGgydeiMS

ERRa Is a Marker of Tamoxifen Response & Survival in Triple-Negative #BreastCancer @YUNews https://t.co/SKFdHXlhgJ

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.